Edward D. Pagani

1.7k total citations
42 papers, 1.3k citations indexed

About

Edward D. Pagani is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Edward D. Pagani has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 23 papers in Molecular Biology and 13 papers in Physiology. Recurrent topics in Edward D. Pagani's work include Nitric Oxide and Endothelin Effects (13 papers), Cardiomyopathy and Myosin Studies (12 papers) and Phosphodiesterase function and regulation (12 papers). Edward D. Pagani is often cited by papers focused on Nitric Oxide and Endothelin Effects (13 papers), Cardiomyopathy and Myosin Studies (12 papers) and Phosphodiesterase function and regulation (12 papers). Edward D. Pagani collaborates with scholars based in United States, France and Italy. Edward D. Pagani's co-authors include F J Julian, Paul D. Allen, Paul J. Silver, Annette E. Oakeley, Nadia N. Malouf, Page A.W. Anderson, R. John Solaro, Alberto Martı́n, Richard Buchholz and Ronald L. Dundore and has published in prestigious journals such as Circulation Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Edward D. Pagani

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Edward D. Pagani

Since Specialization

Citations

This map shows the geographic impact of Edward D. Pagani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward D. Pagani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward D. Pagani more than expected).

Fields of papers citing papers by Edward D. Pagani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward D. Pagani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward D. Pagani. The network helps show where Edward D. Pagani may publish in the future.

Co-authorship network of co-authors of Edward D. Pagani

This figure shows the co-authorship network connecting the top 25 collaborators of Edward D. Pagani. A scholar is included among the top collaborators of Edward D. Pagani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward D. Pagani. Edward D. Pagani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5 1998 ·European Journal of Pharmacology ·Paul J. Silver, Edward D. Pagani, Ronald L. Dundore, Lawrence de Garavilla, (unknown), Edward R. Bacon	8
2	Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo 1996 ·European Journal of Pharmacology ·Lawrence de Garavilla, Edward D. Pagani, Richard Buchholz, Ronald L. Dundore, (unknown), (unknown), (unknown), Phillip F. Pratt, Paul J. Silver	13
3	Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs 1995 ·Academic Radiology ·T. W. Morris, Deborah Dukovic, Edward D. Pagani	5
4	Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones 1995 ·Journal of Medicinal Chemistry ·Baldev Singh, Edward R. Bacon, George Y. Lesher, Shaughnessy Robinson, (unknown), (unknown), Edward D. Pagani, Ross Bentley, Mary J. Connell, L T Hamel, Paul J. Silver	24
5	Species-Dependent Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 58993 and WIN 62005 1995 ·Journal of Cardiovascular Pharmacology ·Ronald L. Dundore, Edward D. Pagani, (unknown), Edward R. Bacon, Baldev Singh, (unknown), Richard Buchholz, Paul J. Silver	5
6	5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase 1994 ·Journal of Medicinal Chemistry ·Roland E. Dolle, Joseph A. Dunn, Mark A. Bobko, Baldev Singh, Joan E. Kuster, Eugene R. Baizman, Alex L. Harris, David G. Sawutz, Deborah Miller, Su Wang, Connie R. Faltynek, (unknown), Jay Sarup, (unknown), Edward D. Pagani, Paul J. Silver	36
7	The Effects of Coronary Injections of Iodixanol, Iopamidol, and Ioxaglate on Contractility and Electrophysiology 1994 ·Investigative Radiology ·T. W. Morris, Deborah Dukovic, Edward D. Pagani	9
8	Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats 1993 ·European Journal of Pharmacology ·Ronald L. Dundore, (unknown), (unknown), (unknown), (unknown), Richard Buchholz, Paul J. Silver, Edward D. Pagani	56
9	Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast 1993 ·European Journal of Pharmacology ·Edward D. Pagani, (unknown), (unknown), Paul J. Silver	25
10	Effect of calcium binding protein modulators on myofibrillar MgATPase activity and cGMP‐inhibitable phosphodiesterase activity from human cardiac muscle 1993 ·Drug Development Research ·Edward D. Pagani, (unknown), Paul Allen, Darcy A. Hille, Paul J. Silver	3
11	Troponin T isoform expression in the normal and failing human left ventricle: a correlation with myofibrillar ATPase activity 1992 ·Steinkopff eBooks ·Page A.W. Anderson, Nadia N. Malouf, Annette E. Oakeley, Edward D. Pagani, Paul D. Allen	30
12	Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function 1992 ·Steinkopff eBooks ·Edward D. Pagani, Richard Buchholz, Paul J. Silver	21
13	Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast 1991 ·European Journal of Pharmacology ·Ronald L. Dundore, Phillip F. Pratt, (unknown), Richard Buchholz, Edward D. Pagani	14
14	Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine. 1991 ·Journal of Pharmacology and Experimental Therapeutics ·Paul J. Silver, Brendan O’Connor, (unknown), (unknown), L T Hamel, Ross Bentley, Edward D. Pagani	22
15	The Effects of Iodixanol and Iopamidol on Hemodynamic and Cardiac Electrophysiologic Parameters In Vitro and In Vivo 1991 ·Investigative Radiology ·Ronald L. Dundore, Paul J. Silver, Alan M. Ezrin, (unknown), Richard Buchholz, (unknown), (unknown), Georg A. Roth, (unknown), Damian M. Bailey, Edward D. Pagani	17
16	Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast 1991 ·European Journal of Pharmacology ·Paul J. Silver, Edward D. Pagani, Lawrence de Garavilla, (unknown), (unknown), Phillip F. Pratt, Richard Buchholz	22
17	Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine 1990 ·Journal of Cardiovascular Pharmacology ·Paul J. Silver, (unknown), Ronald L. Dundore, Alex L. Harris, Edward D. Pagani	22
18	Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Alex L. Harris, Mary J. Connell, Edward Ferguson, Andrew Wallace, (unknown), Edward D. Pagani, Paul J. Silver	93
19	Effects of milrinone on Ca++-sensitivity of myofibrillar Mg-adenosine triphosphatase isolated from normal human and canine hearts. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Adawia A. Alousi, Alison M. Grant, P. David Allen, Edward D. Pagani	8
20	Simple selected ion monitoring method for determination of fosfomycin in blood and urine 1981 ·Journal of Chromatography B Biomedical Sciences and Applications ·Antonio Longo, M. Di Toro, Edward D. Pagani, A. Carenzi	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact